IGF1 and breast cancer: Similarly, basal and maximal ECAR are increased with IGF-1 treatment in human breast cancer cells (Rajoria et al., 2023) and with IGF-1 overexpression in rat dorsal root ganglion (DRG) neurons (Aghanoori et al., 2022).